R&D is the backbone of Lilly

Lilly Research Laboratories (LRL) discover and develop high-quality innovative medicines that help patients live longer, healthier, happier lives. This is done in a reliable and cost-effective manner and in an atmosphere of optimism, teamwork, quality and compliance.

Since 2002, Lilly has registered all Lilly-sponsored Phase II, Phase III and Phase IV clinical studies, conducted anywhere in the world that were initialited on or after October 15, 2002 on www.clinicaltrials.gov. Additionally, Lilly began registering all Phase I clinical studies commencing on or after October 1, 2010.

Our investment in research and development has been sustained at a high level over many years and has resulted in one of the most prolific pipelines in the industry, with more than 60 potential medicines currently in development.

Find out more about our discovery work at lilly.com